(PGE2) has complex effects on airway tone, and the existence of four PGE2 [E-prostanoid (EP)] receptors, each with distinct signaling characteristics, has provided a possible explanation for the seemingly contradictory actions of this lipid mediator. To identify the receptors mediating the actions of PGE2 on bronchomotor tone, we examined its effects on the airways of wild-type and EP receptor-deficient mice. In conscious mice the administration of PGE2 increased airway responsiveness primarily through the EP1 receptor, although on certain genetic backgrounds a contribution of the EP3 receptor was detected. These effects of PGE2 were eliminated by pretreatment with either atropine or bupivacaine and were undetectable in anesthetized mice or in denervated tracheal rings, where only EP2-mediated relaxation of airway smooth muscle was observed. Together, our findings are consistent with a model in which PGE2 modulates airway tone by activating multiple receptors expressed on various cell populations and in which the relative contribution of these receptors might depend on the expression of modifier alleles. PGE2/EP1/EP3-induced airway constriction occurs indirectly through activation of neural pathways, whereas PGE2-induced bronchodilation results from direct activation of EP2 receptors on airway smooth muscle. This segregation of EP receptor function within the airway suggests that PGE2 analogs that selectively activate the EP2 receptor without activating the EP1/EP3 receptors might prove useful in the treatment of asthma. PGE2 receptor; bronchoconstriction; bronchodilation; knockout; nerves SHORTLY AFTER ITS DISCOVERY in the 1960s, prostaglandin E 2 (PGE 2 ) was observed to have potent relaxant effects on airway smooth muscle, making this endogenous lipid an attractive candidate drug for asthma (18,34). However, human studies with aerosolized PGE 2 have demonstrated inconsistent effects on airway tone, with most asthmatics showing a bronchodilator response but some developing profound bronchoconstriction requiring beta agonist rescue (6,19). Ex vivo studies from humans and animals have also shown that PGE 2 can both relax and constrict airway smooth muscle, a paradox explained when it was recognized that PGE 2 could act through more than one receptor (9,20,26).Four distinct cell surface receptors for PGE 2 [E-prostanoid (EP)] have been identified and cloned, each with unique signal transduction mechanisms as a result of coupling to different G proteins (23). Activation of one or a combination of receptors, each which may be differentially expressed on airway smooth muscle, epithelia, neurons, and immune effector cells, results in a specific physiological response. EP2 and EP4 receptors couple to G s , and activation of these receptors results in stimulation of adenylyl cyclase and increases in intracellular cAMP. Various EP3 isoforms, arising from the differential splicing of the EP3 gene, have been identified both in humans and in mice (1,24). Differences in the cytoplasmic domain of the EP3 receptor leads to th...